about
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic reviewWater intoxication in patients with psychiatric illnessInvestigation of the metabolism of substance P at the blood-brain barrier using capillary electrophoresis with laser-induced fluorescence detection.Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorderSchizophrenia and viral infection during neurodevelopment: a focus on mechanisms.Neuropeptides involved in the pathophysiology of schizophrenia and major depression.Where and what is the paralaminar nucleus? A review on a unique and frequently overlooked area of the primate amygdala.Studies on the conformation, enzymatic degradation, pharmacological potency, and binding properties in brain tissue of cholecystokinin-8 and new related peptides.Somatostatinergic systems: an update on brain functions in normal and pathological aging.Distribution and localization of regulatory peptides.Neuropeptides, behavior, and aging.Cholecystokinin, dopamine, and schizophrenia: recent progress and current problems.Neonatal insult to the hippocampal region and schizophrenia: a review and a putative animal model.Interactions of cholecystokinin and dopamine in the nucleus accumbens.Merck, Sharp & Dohme Prize for Young Psychopharmacologists: A history of frontal and temporal lobe aspects of the neuropharmacology of schizophrenia.Reduced cholecystokinin levels in the limbic lobe in schizophrenia. A marker for pathology underlying the defect state?Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine.The neuropsychology of schizophrenia: A perspective from neurobehavioral geneticsWhy don't preschizophrenic children have delusions and hallucinations?
P2860
Q28077391-6E7B6295-F77D-4BE5-92D3-C0DAA8C1FC37Q28307367-3468DF7D-8C7E-49D9-A659-B7D831C53511Q30667130-1A450ABB-2F60-42A1-99BF-A3B113081CA5Q33628457-728824B9-667E-4E04-A6F3-F2262C7B24ABQ34416948-234179EC-B733-4A87-8D88-5BB1FCF19D6BQ35130197-587D0962-7EA6-4C19-A401-D2AF2D0B30F3Q35566621-C53571E2-9E68-482E-8BA7-B21B996ADCDDQ36423695-7C472B16-6416-4372-9B7A-74CE2C0DEE16Q36449496-C3AD72A5-F926-4F0F-B87C-3400B8EBCB9DQ38152772-3CCC6765-48CE-459C-A571-4390C8681CC1Q39498368-CEBC61AB-8A43-4B7C-AFED-71A655926934Q39548142-02FA1633-AC02-4704-8E53-70318623AF2EQ41180020-A6C35E91-9698-4FFA-AB88-04D2580AC401Q41879525-AA7D149A-94AB-4F05-8415-8B36ED1C2BFFQ48400379-D1A367A9-1563-4B5C-BFE0-CEB649D8DEC3Q48578177-935C66B5-6560-4A6A-AA88-C0206246481CQ50488312-36EC4318-7E5A-4470-A5F9-41ECA22839D3Q56896418-91282644-79B4-4E1F-977D-190FEEF0CA78Q57403541-0708B355-9FA8-43AF-8207-08431EA0C8D5
P2860
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh-hant
name
Peptides, the limbic lobe and schizophrenia.
@en
Peptides, the limbic lobe and schizophrenia.
@nl
type
label
Peptides, the limbic lobe and schizophrenia.
@en
Peptides, the limbic lobe and schizophrenia.
@nl
prefLabel
Peptides, the limbic lobe and schizophrenia.
@en
Peptides, the limbic lobe and schizophrenia.
@nl
P2093
P1433
P1476
Peptides, the limbic lobe and schizophrenia.
@en
P2093
A J Bacarese-Hamilton
D O'Shaughnessey
E C Johnstone
G McGregor
G W Roberts
I N Ferrier
P304
P356
10.1016/0006-8993(83)90095-1
P407
P577
1983-12-01T00:00:00Z